
1. Technology overview
Moon Surgical is a surgical robotics company with offices in Paris, France (117 Quai de Valmy) and San Carlos, California. It was formerly known as MastOR and describes a vision of an operating room that is sustainable, efficient and digitalized.
The Maestro Platform is a laparoscopy assistance robot used together with the surgeon's preferred instruments, paired with Maestro Insights software that surfaces actionable data from the procedure. The company reports CE marking of the commercial system in 2023 and several FDA 510(k) clearances, the latest covering the ScoPilot AI capability in March 2025, with deployments in hospitals and an ambulatory surgery center.
2. Highlighted features & specifications
- Total control: the surgeon directs the procedure with robotic assistance.
- Preferred instruments: operates with the instruments the surgeon already uses.
- Digitalized operating room: captures procedure data for the OR of the future.
- Maestro Insights: software that provides actionable insights from surgery.
- ScoPilot: AI-enhanced intraoperative capability cleared by the FDA in March 2025.
- Specialties: laparoscopic cholecystectomy and gynecological surgery.
3. Potential application
Private hospitals in Vietnam running laparoscopic cholecystectomy and gynecological programs can evaluate robotic assistance. Ambulatory surgery centers can use a compact platform to extend minimally invasive capacity. Teaching hospitals can use captured procedure data for surgical training and quality review.
4. Benefits
Keeps the surgeon in control while adding robotic assistance for laparoscopic procedures. Works with the surgeon's preferred instruments rather than a closed set. Adds AI-based intraoperative capability and data through Maestro Insights. Holds ISO 27001:2022 and SOC 2 certifications for data security, according to the company.
5. Market trends & opportunities
Hospitals and ambulatory surgery centers are adopting robotic and AI-assisted laparoscopy to improve consistency and efficiency. Southeast Asian private hospitals are expanding minimally invasive surgery programs, which creates demand for lower-footprint robotic assistance. The company's NVIDIA edge AI collaboration reflects the move toward data-driven operating rooms.
6. Other information
Offices in Paris and San Carlos, CA. Formerly MastOR; seed funding from Sofinnova Partners announced July 2020, $55.4M raised May 2023 led by Sofinnova and NVIDIA. CE mark 2023, FDA 510(k) clearances in Dec 2022, Jun 2024 and Mar 2025. Discovered via EIC-related lists; the site itself does not mention EIC.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































